throbber
j. Pharm. Pharmacol. 1997, 49:241-245
`Received July 9, 1996
`Accepted November 5, 1996
`
`© 1997 J. Pharm. Pharmacol.
`
`In-vitro Permeability of the Human Nail and of a Keratin
`Membrane from Bovine Hooves: Penetration of Chloramphenicol
`from Lipophilic Vehicles and a Nail Lacquer
`
`DIRK MERTIN AND BERNHARD C. LIPPOLD
`
`Department of Pharmaceutical Technology, Heinrich-Heine-University, Universitiitsstrasse 1, D-40225
`Diisseldorf, Germany
`
`Abstract
`
`Lipophilic vehicles and especially nail lacquers are more appropriate for topical application on the nail than
`aqueous systems because of their better adhesion. This work has, therefore, studied the penetration through the
`human nail plate of the model compound chloramphenicol from the lipophilic vehicles medium chain
`triglycefides and n-octanol and from a lacquer based on quaternary poly(methyl methacrylates) (Eudragit
`RL). The results were compared with data obtained with a keratin membrane from bovine hooves.
`If the swelling of the nail plate or the hoof membrane is not altered by use of lipophilic vehicles, the
`maximum flux of the drug is independent of its solubility in the vehicle and is the same as that from a saturated
`aqueous solution. These vehicles are not able to enter the hydrophilie keratin membrane because of their non-
`polar character and so cannot change the solubility of the penetrating substance in the barrier. If the
`concentration of the drug in the nail lacquer is sufficiently high, the maximum flux through both barriers
`equals that from aqueous vehicles or even exceeds it because of the formation of a supersaturated system.
`Penetration through the nail plate follows first order kinetics after a lag-time of 400 h. The course of penetration
`through the hoof membrane is initially membrane-controlled and later becomes a matrix-controlled process
`because of the membrane’s greater permeability. Chloramphenicol is dissolved in the lacquer up to a
`concentration of 31%. The relative release rates from these solution matrices are independent of the drug
`concentration but they decrease on changing to a suspension matrix.
`These results show that drug flux is independent of the character of the vehicle and that penetration of the
`drug is initially membrane-controlled and changes to being matrix-controlled as the drug content of the lacquer
`decreases.
`
`The nail plate and the bovine hoof membrane behave like
`hydrophilic gel membranes rather than lipophilic partition
`membranes (Mertin & Lippold 1997). The maximum flux of a
`drug through both barriers is primarily a function of its water-
`solubility. Because aqueous solutions are not important in the
`topical therapy of nail infections, due to their insufficient
`adhesion, lipophilic vehicles or nail lacquers were investigated
`to determine whether the flux from these reached the max-
`imum obtained from aqueous vehicles.
`Studies of the penetration of the antifungal agents ciclopirox
`(Hiinel & Ritter 1990; Nolting & Seebacher 1993) and amor-
`olfine (Polak & Zaug 1990; Franz 1992; Polak 1992) show that
`active drug concentrations are obtained in the whole nail plate
`after a few days. Little is, however, known about the rela-
`tionship between flux and concentration in the lacquer. The
`influence of the release on the kinetics of nail penetration have,
`moreover, not yet been described.
`According to Fick’s law (eqn 1) the penetration rate from an
`aqueous solution at sink conditions is directly proportional to
`the drug concentration in the barrier on the donor side (Car))
`(Mertin & Lippold 1997):
`
`dM/dt = DBACBo/hB
`
`(1)
`
`in which dM/dt is the amount penetrating per unit time, Dn the
`
`Correspondence: B. C. Lippold, Department of Pharmaceutical
`Technology, Heinrich-Heine-University, Universit~tsstrasse 1, D-
`40225 Diisseldorf, Germany.
`
`effective diffusion coefficient in the barrier, A the diffusion
`area, and ha the thickness of the barrier. For a suspended
`substance in a given vehicle, the saturation concentration
`(C~BD) forms on the donor side owing to partition. Then the
`maximum concentration gradient causes the maximum flux:
`
`J~x = dM.~,IdtA, = DBCsBD/hB
`
`(2)
`
`As long as the vehicle does not change the barrier (e.g. by
`deswelling), the maximum flux from a suspension is inde-
`pendent of the vehicle (Lippold 1984). The swelling of
`hydrophilic gel membranes should be unchanged in contact
`with lipophilic vehicles as long as they also stay in contact
`with an aqueous solution. Simulating the swelling of a living
`nail, which is ventrally supplied by the richly vasculated nail
`bed, by using an aqueous solution as acceptor and a lipophilic
`vehicle as donor, the fiux from a saturated solution should
`equal the maximum flux from an aqueous suspension assuming
`an identical extent of swelling.
`To test this hypothesis, the model compound chlor-
`amphenicol was used because it is relatively highly soluble in
`water, which causes sufficiently high fluxes, and it is analyti-
`cally easy to determine, through both the nail plate and the
`hoof membrane. Its molecular size is, moreover, in the range of
`most antimycotics and the results can, therefore, be transferred
`to these drugs. Differences between the solubilities of chlor-
`amphenic01 in pH 7.4 phosphate buffer on the one hand and
`in medium-chain triglycerides and n-octanol on the other
`
`i
`
`e
`
`9
`
`?
`
`)
`
`t
`
`0
`
`it
`
`ARGENTUM EX1022
`
`Page 1
`
`

`

`242
`
`DIRK MERTIN AND BERNHARD C. LIPPOLD
`
`Table 1, Solubility of chloramphenicol in pH 7.4 phosphate buffer,
`n-octanol and medium-chain triglycefides at 32°C.
`
`Vehicle
`
`Solubility (mg L-*)
`
`Studies with different drug concentrations in the polymer
`(from 2.2 to 47-6%) should show whether penetration from the
`lacquer is matrix- or membrane-controlled.
`
`Phosphate buffer, pH 7.4
`n-Octanol
`Medium-chain triglycerides
`
`N=3, mean + s.d.
`
`4520 4-64
`23210 4- 767
`2350 4- 13
`
`(Table 1) seem to be large enough to indicate a possible
`influence of drug solubility in the vehicle on the maximum flux
`through the barrier.
`Results obtained using lipophilic liquids should be trans-
`ferable to nail lacquers, assuming that membrane diffusion,
`and not release from the polymer, is the rate-limiting step. For
`both barriers, however, it must be investigated whether the
`penetration rate is controlled by the permeability of the barrier
`as well as the release of drug from the lacquer. The liberation
`of a substance which is suspended or dissolved in a nail lacquer
`should follow kinetics typical of a matrix system. From Fick’s
`first law Higuchi (1961) developed an equation for the release
`of a suspended drug from a matrix (sink conditions):
`
`Q = A~/(D~frCs(2C0 - Cs)t)
`
`(3)
`
`Where Q is the amount of drug released at time t, A is the
`release area, D~ff is the effective diffusion coefficient in the
`matrix, Cs is the solubility of the drug in the matrix, and Co is
`the initial concentration of the drug in the matrix.
`On the premise that Co>> Cs equation 3 can be reduced to:
`
`Q = A~/(2De~CsC0t)
`
`(4)
`
`Higuchi also deduced an equation describing the course of
`liberation of a drug which is completely dissolved in the matrix
`(up to 30% release, sink conditions):
`
`Q = 2AC0~!(D~irt/n)
`
`Transformation of this equation leads to:
`
`Q/Q0 = (2A/VL)~/(D~fft/n)
`
`(5)
`
`(6)
`
`in which Qo is the initial amount of drug in the matrix and VL
`the matrix volume. Equation 6 shows that the relative release
`rate (Q/Qo) is, in contrast with equation 4, independent of the
`amount of drug incorporated and so enables distinction
`between solution and suspension matrix.
`The release rate can deviate from the ideal ~/t kinetic,
`especially at the beginning of the process, if the drug has to
`penetrate an adherent membrane or aqueous layer after leaving
`the matrix. Roseman & Higuchi (1970) described the course
`of penetration from such systems by combining equations 1
`and 4.
`This work has investigated the penetration of chlor-
`amphenicol from lacquers based on quaternary poly(methyl
`methacrylates) with dibutyl sebacate as a plasticizer through
`the nail plate and the hoof membrane. Eudragit RL was used
`because of its ten-fold higher permeability in comparison with
`Eudragit RS (Lehmann 1989). Because previous results have
`shown the permeability characteristics of both barriers to be
`similar (Mertin & Lippold 1997), most of the investigation was
`performed with the hoof membrane.
`
`Materials and Methods
`
`Chemicals
`A phosphate buffered saline solution, pH 7-4, was used as
`acceptor. Chloramphenicol was obtained from Caesar & Lor-
`entz (Hilden, Germany), medium-chain triglycerides (Miglyol
`812) from HiJls AG (Witten, Germany), n-octanol and
`methanol from J. T. Baker (Deventer, Netherlands), Euclragit
`RL PO from Ri3hm GmbH (Darmstadt, Germany) and dibutyl
`sebacate (Rilanit DBS) from Henkel KGaA (Diisseldorf, Ger-
`many). HPLC-grade methanol (chromasolv methanol) is a
`product of Riedel-de-Hafin (Seelze, Germany).
`
`Penetration studies
`The modified Franz diffusion cells, the preparation of the nails
`and the hoof membranes and the performance of the penetra-
`tion studies have been described in an earlier publication
`(Mertin & Lippold 1997). For experiments with lipophilic
`liquid vehicles, chloramphenicol was used in a suspended form
`with its maximum thermodynamic activity. The formation of a
`saturated solution was guaranteed by stirring at 32°C for 48 h.
`Despite occasional very long penetration times no visual
`degradation of the nails was observed.
`
`Analytical conditions
`The HPLC method differs from that described earlier (Mertin
`& Lippold 1997) in one aspect: the mobile phase acetonitrile-
`water (3: 1) was pumped at flow rates ranging from 1.0 to
`1.25 mL min- I.
`
`Composition and application of the lacquer solution
`The effect of concentration was examined by varying the
`amount of chloramphenicol between 0.5 and 20% of the lac-
`quer solution-equivalent to between 2.2 and 47.6% of the dry
`lacquer. The formulations were: Eudragit RL PO, 20-0%;
`dibutyl sebacate, 2.0%; chloramphenicol, 0-5, 5-0, 10-0 and
`20-0%; and methanol to 100%.
`The swollen membrane was fixed in the empty diffusion cell
`and dried under ambient conditions for 2 h. A 200-pm film
`resulted after application of the lacquer solution (500 I.tL on to
`about 2.5 cm2 hoof membrane and 120pL on to 0.64cm2 nail
`plate), initial drying with warm air for a period of 30 min and
`final drying at room temperature for 24 h. The filling of the
`acceptor compartment started the experiment.
`
`Results and Discussion
`
`Penetration from lipophilic liquids
`Phosphate buffer pH 7-4, n-octanol and medium-chain trigly-
`cerides were used as donors (medium-chain wiglyeerides only
`in experiments with hoof membrane). Table 2 shows max-
`imum fluxes (Jm~ (10001ira)) from the different vehicles,
`standardized to a barrier thickness of 1000 ttm corresponding
`to the average thickness of the big-toe nail.
`
`Page 2
`
`

`

`PERMEABILITY OF NAIL AND KERATIN MEMBRANE
`
`243
`
`Table 2. Maximum flux of ehloramphenicol, standardized to a barrier thickness of 1000 gm
`(Jma~(1000 lam)), from different vehicles through hoof membrane and nail plate at 32°C.
`
`Vehicle
`
`Maximum flux of chloramphenieol
`(mgem-2s-I)
`
`Hoof membrane
`
`Nail plate
`
`Phosphate buffer, pH 7.4
`n-Octanol
`Medium-chain triglycerides
`
`4.074- 1-18 × 10-6
`3.40+0.68 × 10-6
`4.064- 1-00 × 10-6
`
`8.21 4-2-11 × 10-7
`9.134-0.63 × 10-7
`n.d.*
`
`*Not determined. N = 3 or 4, mean 4- s.d.
`
`O
`
`G.
`
`t)
`
`O
`
`!
`
`Fluxes through the hoof membrane are forty-fold those
`through the nail plate, confirming the different permeability of
`the barriers (Mertin & Lippold 1997). It is, however, more
`interesting that the vehicle has no influence on the maximum
`flux. There is no significant difference (P=0-05) between the
`fluxes from the various vehicles through both barriers. Because
`the fluxes from lipophilic vehicles are equal to those from
`aqueous saturated solutions, the assumption that the flux is
`independent of the character of the vehicle is completely
`confirmed. Obviously, a saturated solution and, therefore, the
`maximum concentration gradient forms on the donor side of
`the water-swollen membrane owing to distribution. Neither
`medium-chain triglycerides nor n-octanol have significant
`influence on keratin swelling or the solubility of chlor-
`amphenicol in the membrane. It is of practical significance that
`the therapeutically desired maximum flux is reached as soon as
`the drug is present at its maximum thermodynamic activity, i.e.
`the saturated state. Although low solubility can be used to save
`drugs, very low solubilities lead to emptying effects, i.e. the
`flux cannot be maintained over the whole period of application.
`This result is of great importance in respect of drug penetration
`from nail lacquers.
`
`Penetration from nail lacquers
`Kinetics of penetration. Figs 1 and 2 illustrate the concentra-
`tion-dependence of the diffusion of chloramphenicol from
`Eudragit RL lacquers through the hoof membrane. Plotting
`the amount penetrated against t gives linear relationships after
`a lag-time of a few hours; this is typical of matrix control (Fig.
`1). As expected for a solution matrix, the rate of penetration of
`chloramphenicol increases with the concentration of the drug
`in the matrix between 2.2 and 18.5% and so the relative release
`rates (i.e. the amount penetrated relative to the total amount in
`the lacquer) remain constant. Increasing the concentration in
`the lacquer to 47.6% has no effect on the penetration rate,
`however, and so the relative rates decrease. This proves that,
`except for the lacquer containing 47.6% chloramphenicol, all
`systems are solution matrices as the relative release rates are
`independent of the amount of drug incorporated, in accordance
`with equation 6. Because the relative release rate decreases by
`half for the 47.6% lacquer, this, therefore, can be characterized
`as a suspension matrix. Fig. 1 does not enable distinction
`between matrix- and membrane-controlled processes. For
`membrane-controlled release from a solution matrix, first-
`order kinetics are expected. The plot of the amount of drug
`remaining in the lacquer (logarithmic scale) against time (Fig.
`
`50’
`
`A
`
`~ 40-
`
`30.
`
`E= 20.
`o
`e
`’<10.
`
`0
`
`o i
`
`Time 1/2 (h1/2)
`
`FIG. 1. Percentage penetration of ch]oramphenicol from Eudragit RL
`lacquers containing different concentrations, CL, of drug through the
`hoof membrane at 32°C (n =4, mean 4-s.d.). Chloramphenicol con-
`centration: ¯ 2.2%, [] 18.5%, ¯ 31.3%, ¯ 47.6%.
`
`1 oo
`
`o 90 8o
`
`70
`
`60
`
`50
`
`lb
`
`2’0
`
`Time (h)
`
`’ 5O
`
`FIG. 2. Penetration of chloramphenicol from Eudragit RL lacquers
`containing different concentrations, CL, of drug, through the hoof
`membrane at 32°C, plotted as the amount of drug remaining in the
`lacquer (Qo - Q; n = 4, mean 4- s.d.). Chloramphenicol concentration:
`¯ 2.2%, [] 18.5%, ¯ 31.3%, ¯ 47.6%.
`
`2) shows, because all curves are flattening, that membrane
`control does not occur over the whole period.
`The ideal ~t kinetics follow after the expiry of the lag-time
`because of the initially predominant membrane control. Delayed
`drug release from silicone matrices through aqueous adherent
`layers results in similar penetration profiles (Haleblian et al
`1971; Roseman 1972).
`
`Page 3
`
`

`

`244
`
`DIRK MERTIN AND BERNHARD C. LIPPOLD
`
`Release exponent, n, for the penetration kinetics of ch!oramphenicol from Eudragit RL lacquers
`Table 3.
`through the hoof membrane at different drug concentrations.
`
`CL (%) Calculated according to equation 7* Calculated according to equation 8I"
`
`Exponent (n)
`
`r~
`
`Exponent (n)
`
`tt,s (11)
`
`2.2
`18-5
`31.3
`47.6
`
`0.67 -4- 0.04
`0.734-0-05
`0.70 ± 0.02
`0.64 -I- 0-03
`
`0.9990
`0.9917
`0.9995
`0.9995
`
`0.56 4- 0-03
`0.504-0.05
`0.62 -t: 0.03
`0.65 -4- 0.04
`
`1.55 4- 0.27
`3.28+0.19
`1-45 4- 0.28
`0.09 4- 0.18
`
`0.9999
`0.9985
`0.9999
`0.9999
`
`*Q/Qo = kt~- tQ/Qo = k(t - tlag)n. ZCorrelation coefficient of the regression line. N = 4, mean 4- s.d.
`
`The course of the drug release from a dosage form can be
`expressed by a semi-empirical function (Peppas 1985):
`
`Q/Q0 = kt~
`
`(7)
`
`Where Q/Qo has the same meaning as in equations 3 and 6, k is
`the release-rate coefficient, and n is an exponent which
`describes the kinetics. If release is delayed, neglecting the lag-
`time can lead to incorrect conclusions about the penetration
`kinetics. In this circumstance equation 8 offers a better
`approach:
`
`Q/Q0 = k(t - tlag)n
`
`(8)
`
`The release exponent (n) and the lag-time can be determined
`by a computer-aided, iterative method. Here the lag-time is
`established by a progressive shift of the experimental curve to
`the left parallel to the abscissa, beginning with data from 5 h
`onwards, inserting in the logarithmic form of equation 7 and
`subsequent linear regression to obtain the best curve fit
`(Lindner 1994). Table 3 shows the liberation parameters
`determined directly with equation 7 and iteratively with
`equation 8.
`Neglecting the lag-phase normally leads to overestimation
`of the release exponent n and a worse fit of the calculated curve
`to the experimental data; this is reflected in a lower correlation
`coefficient. With the exception of the lacquer containing
`47.6% chloramphenicol, the lag-time ranges from 1-4 to 3.3 h
`and agrees with the values determined graphically from Fig. 1.
`The iterative exponents (0-50 to 0.62, Table 3) are in the range
`expected for pure matrix release (n =0.5) and confirm the
`visual assessment of the profiles. The exponent of the 47.6%
`lacquer is significantly different from unity which is expected
`for completely membrane-controlled release from a saturated
`vehicle. These results, on the other hand, correspond with the
`assumption of initial membrane control changing to matrix
`
`control as the drug content of the lacquer decreases.
`
`Fluxes from nail lacquers compared with liquid vehicles
`The profile between the first and the sixth hours after the start
`of the experiment was evaluated to determine the fluxes
`through the hoof membrane. Here the penetration rate is
`highest and there is an approximately linear relationship
`between the amount penetrated and time. This behaviour, not
`typical of matrix control, corresponds to the initial membrane-
`control. The expected first order kinetics (only dissolved drug
`in the lacquer) results in a more or less linear course for an
`
`For saturated solutions (real steady-state), zero order kinetics
`prevail, which causes a linear increase of the concentration in
`the acceptor. Not before a sufficiently large emptying zone of
`the drug has developed, causing also a decrease in con-
`centration in the membrane, does the process become matrix-
`controlled.
`As the maximum flux is, in addition to antifungal power, the
`most important parameter for predicting the therapeutic effi-
`cacy of anfimycotics, the penetration of chloramphenicol
`through the nail in man was investigated with a single for-
`mulation (31-3%). Fig. 3 shows the low penetration rate and
`large lag-time in comparison with the thinner hoof membrane.
`The lag-time (about 400h) is significantly longer than for
`penetration from an aqueous suspension (about 200h).
`Because both fluxes do not differ from each other in the
`steady-state (Table 4), the distinction cannot be explained by
`the different diffusion coefficients. Possibly the initially dry
`nail plate is slowly hydrated under the occlusive lacquer after
`contact with the acceptor medium, whereupon the partition
`equilibrium between polymer and nail plate and, therefore, the
`formation of the maximum concentration gradient, is delayed.
`The flux was calculated from the steady-state values between
`t=670 and 940h. Because of the lower penetration rate it
`should stay constant over a longer period than for the hoof
`membrane, for which the emptying area in the matrix widens
`after a short time and then the course of diffusion corresponds
`to classical ~/t-kinetics. Thus, the hoof membrane has to be
`
`20.
`
`15
`
`-,~
`
`g
`
`0.20
`
`0-15
`
`0.10
`
`E
`
`0
`
`0-05
`
`0
`
`200 400 600
`
`Time (h)
`
`0-00
`800 1000
`
`FIG. 3. Penetration of chloramphenicol (CL = 31.3%) from Eudragit
`RL lacquer through the hoof membrane (thickness, dB, = 104 pm) and
`the nail plate (ds=953pm) at 32°C (n=4, mean_-h s.d.). QH and QN
`&re, respectively, the amounts of drug penetrated through hoof mem-
`~-’~ne (O) and nail nlate (@).
`
`Page 4
`
`

`

`. Table 4. Flux of chloramphenicol through the hoof membrane and
`the nail plate at 32°C from Eudragit RL lacquers containing different
`concentrations of drug, CL, and from a saturated solution in pH 7-4
`phosphate buffer.
`
`Concentration in the
`lacquer (%)
`
`Maximum flux of ehloramphenicol
`(J(1000 btm); mgcm-2s- I)
`
`Hoof membrane
`
`Nail plate
`
`2.2
`18.5
`31.3
`47.6
`Saturated solution in
`phosphate buffer 5.32+1.62 × 10-6
`
`3-104-0.39 x 10 7
`4.344-1.27 × 10-6
`7.264-1.75 × 10-6
`8-114-2.16 x 10-6
`
`n.d.*
`8.024-1.81 × I0-8
`n.d.
`n.d.
`
`8.214-2-ll x 10-s
`
`*Not determined. Results are standardized to dB=10001.tm.
`n=3-7, mean + s.d.
`
`used with caution as a model for studying controlled-release
`systems for application on nails.
`The fluxes of chlnrarnphenicol, standardized to a barrier
`thickness of 1000 p.m are in the same range as the maximum
`fluxes from aqueous suspensions (Table 4). Firstly, it is sur-
`prising that the flux through the hoof membrane from the more
`highly concentrated lacquers (for the 47.6% lacquer it is even
`statistically significant, P = 0-05) is greater than that from an
`aqueous suspension. This can only be explained by the
`assumption of the formation of a supersaturated solution in the
`barrier. For the 31.3% Eudragit RL lacquer the development of
`a thermodynamically unstable supersaturated solution could be
`proved by polarization microscopy. This state seems also to be
`formed on the donor side of the hoof membrane, because of the
`distribution equilibrium, and remains until crystallization starts
`or the concentration falls below the solubility as a result of the
`emptying of the matrix. As the flux from the 18.5% lacquer is
`not significantly lower than the maximum flux from water, it
`has to be assumed that the solubility of chlorampbenicol in the
`poly(methyl rnethaerylate) lacquer is in the same range. These
`findings are confirmed by the results of the nail plate--the flux
`from the 18.5% lacquer equals the maximum flux from water.
`The lacquer presented, consisting of a highly permeable
`quaternary poly(methyl methacrylate) (Eudragit RL) and
`dibutyl sebacate as a plasticizer, is, therefore, a suitable dosage
`form for achieving high drug fluxes through the nail plate and
`the hoof membrane. By addition of a sufficiently high con-
`centration of drug it is possible to achieve penetration rates
`which correspond to those from saturated liquid vehicles
`
`.ATh .... ~E
`
`243
`
`(water or non-aqueous solvents) or even exceed those owing to
`the temporary formation of a supersaturated system. Because
`of the low permeability of the nail plate the release rate of the
`lacquer is not important in this instance. The rapid develop-
`ment of the partition equilibrium between lacquer and barrier
`is, however, significant and so high-swelling polymers
`(Eudragit RL) have to be preferred. It must, however, be
`considered that the dried lacquer remains water-insoluble when
`it becomes more hydrophilic-otherwise it would be removed
`by washing and, therefore, the application intervals have to he
`shortened. On the other hand, the occlusivity of the nail lac-
`quer is of some importance; this is probably increased for
`poorly swelling polymers with low water-vapour permeability.
`
`References
`
`Franz, T. J. (1992) Absorption of amorolfine through human nail.
`Dermatology 184 (Suppl. 1): 18-20
`Haleblian, J., Runkel, R., Miiller, N., Christopherson, J., Ng, K. (1971)
`Steroid release from silicone eI2-stomer containing excess drug in
`suspension. J. Pharm. Sci. 60:541-545
`H~nel, H., Ritter, W. (1990) Formulation. In: Ryley, J. F. (ed.)
`Chemotherapy of Fungal Diseases (Handbook of Experimental
`Pharmacology, Vol. 96). Springer, Berlin, pp 251-278
`Higuchi, T. (1961) Rate of release of medicaments from ointment
`bases containing drugs in suspension. J. Pharm. Sci. 50:874--875
`Lehmann, K. (1997) Chemistry and application properties of poly-
`methacrylate coating systems. In: McGinity, J. W. (ed.) Aqueous
`Polymeric Coatings for Pharmaceutical Dosage Forms. Marcel
`Dekker, New York, pp 101-176
`Lindner, W. D., M0ckel, J. E., Lippold, B. C. (I996) Controlled release
`of drugs from hydrocolloid embeddings. Pharmazie 51:263-272
`Lippold, B. C. (1984) Biopharmazie. Wissenschafdiche Verlagsge-
`sellschaft, Stuttgart, pp 106-108
`Mertin, D., Lippold, B. C. (1997) In-vitro permeability of the human
`nail and of a keratin membrane from bovine hooves: influence of the
`partition coefficient octanol/water and the water solubility of drugs
`on their permeability and maximum flux. J. Pharm. Pharmacol. 49:
`30-34
`Nolting, S., Seebacher, C. (1993) Ciclopiroxolamin - Wegweiser
`topischer Mykose-Therapie, Universit~tsverlag Jena, .lena
`Peppas, N. A. (1985) Analysis of Fickian and non-Fickian drug release
`from polymers. Pharm. Acta Helv. 60:110-111
`Polak, A. (1992) Kinetics of amorolfine in human nails. Mycoses 36:
`101-103
`Polak, A., Zaug, M. (1990) Amorolfine. In: Ryley, L F. (ed.) Che-
`motherapy of Fungal Disease (Handbook of Experimental Pharma-
`cology, Vol. 96). Springer, Berlin, k’P 505-52l
`Roseman, T. J. (1972) Release of steroids from a silicone polymer. J.
`Pharm. Sci. 61:46-50
`Roseman, T. J., Higuchi, W. I. (1970) Release of medroxyprogesterone
`acetate from a silicone polymer. J. Pharm. Sei. 59:353-357
`
`¢).
`
`O
`
`o
`
`lI.
`
`o
`
`i ~,ii
`
`:i
`
`Page 5
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket